Phase 1/2a, open‐label, multicenter study of RM ‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma

1161PIntratumoral and peripheral exploratory biomarker analysis in patients with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC) treated with RM-1929 photoimmunotherapy

(2019) J D Bui et al.   ANNALS OF ONCOLOGY

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

(2019) Barbara Burtness et al.   LANCET

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma

(2018) Marc Hamoir et al.   Cancers

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

(2018) Ezra E W Cohen et al.   LANCET

A synthesis of the world's guidelines on photodynamic therapy for non-melanoma skin cancer

(2018) Colin A. Morton   GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

Photoinduced Ligand Release from a Silicon Phthalocyanine Dye Conjugated with Monoclonal Antibodies: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy

(2018) Kazuhide Sato et al.   ACS Central Science

Carotid blowout syndrome: modern trends in management

(2018) Carlos Suárez et al.   Cancer Management and Research

Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity

(2017) Mikako Ogawa et al.   Oncotarget

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

(2016) Tanguy Y Seiwert et al.   LANCET ONCOLOGY

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

(2016) Robert L. Ferris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Utility of Surgery/Radiotherapy in Distant Metastatic Head and Neck Squamous Cell Carcinoma

(2016) Tapan D. Patel et al.   OTOLARYNGOLOGY-HEAD AND NECK SURGERY

Management and prevention of acute bleedings in the head and neck area with interventional radiology

(2016) Katharina Storck et al.   Head & Face Medicine

Evaluation of oxygen dependence on in vitro and in vivo cytotoxicity of photoimmunotherapy using IR-700–antibody conjugates

(2015) Shun Kishimoto et al.   FREE RADICAL BIOLOGY AND MEDICINE

Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy

(2012) Makoto Mitsunaga et al.   BMC CANCER

A systematic review of head and neck cancer quality of life assessment instruments

(2012) Bukola Ojo et al.   ORAL ONCOLOGY

Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules

(2011) Makoto Mitsunaga et al.   NATURE MEDICINE

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

(2008) Jan B. Vermorken et al.   NEW ENGLAND JOURNAL OF MEDICINE